Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (20)

2024

  1. Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population

    Biomedicines, Vol. 12, Núm. 2

2023

  1. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  2. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. Clinical trials in pediatric ALS: a TRICALS feasibility study

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 23, Núm. 7-8, pp. 481-488

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival

    Cells, Vol. 9, Núm. 3

  2. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

2017

  1. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases

    Neurobiology of Aging, Vol. 49, pp. 52-59

  2. Lipid raft ER signalosome malfunctions in menopause and Alzheimer's disease

    Frontiers in Bioscience - Scholar, Vol. 9, Núm. 1, pp. 111-126

2016

  1. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

2015

  1. Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain

    Brain

  2. Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 9, pp. 2608-2617

2013

  1. Analysis of the C9orf72 Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide

    Human Mutation, Vol. 34, Núm. 1, pp. 79-82

2012

  1. A pathogenic mechanism in huntington's disease involves small CAG-repeated RNAs with neurotoxic activity

    PLoS Genetics, Vol. 8, Núm. 2

  2. JNK/ERK/FAK Mediate promigratory actions of basic fibroblast growth factor in astrocytes via CCL2 and COX2

    NeuroSignals, Vol. 20, Núm. 2, pp. 86-102

  3. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease

    Human Molecular Genetics, Vol. 21, Núm. 3, pp. 495-510

2011

  1. Glaucoma patients present increased levels of diadenosine tetraphosphate, Ap4A, in the aqueous humour

    Experimental Eye Research, Vol. 92, Núm. 3, pp. 221-226

1998

  1. Tratamiento percutaneo de las estenosis biliares benignas

    Radiologia, Vol. 40, Núm. 6, pp. 375-382

1979

  1. LA PROBLEMATICA DEL ENFERMO CORONARIO Y LA ANESTESIA

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 26, Núm. 5, pp. 409-423